Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
Candida antigen
MMR
immunotherapy
warts
Journal
Journal of cutaneous medicine and surgery
ISSN: 1615-7109
Titre abrégé: J Cutan Med Surg
Pays: United States
ID NLM: 9614685
Informations de publication
Date de publication:
Historique:
pubmed:
4
2
2021
medline:
15
12
2021
entrez:
3
2
2021
Statut:
ppublish
Résumé
Intralesional immunotherapy has been effectively used in the treatment of warts; however, comparative studies between different antigens are limited. To evaluate the efficacy and safety of intralesional measles, mumps, and rubella (MMR) vaccine compared with intralesional Sixty-eight adult patients with multiple common and plantar warts were randomly assigned into two groups, each containing 34 patients. The first group received intralesional MMR vaccine, while the second group received intralesional The overall therapeutic response was higher in the Intralesional MMR and intralesional
Sections du résumé
BACKGROUND
BACKGROUND
Intralesional immunotherapy has been effectively used in the treatment of warts; however, comparative studies between different antigens are limited.
OBJECTIVE
OBJECTIVE
To evaluate the efficacy and safety of intralesional measles, mumps, and rubella (MMR) vaccine compared with intralesional
METHODS
METHODS
Sixty-eight adult patients with multiple common and plantar warts were randomly assigned into two groups, each containing 34 patients. The first group received intralesional MMR vaccine, while the second group received intralesional
RESULTS
RESULTS
The overall therapeutic response was higher in the
CONCLUSION
CONCLUSIONS
Intralesional MMR and intralesional
Identifiants
pubmed: 33533654
doi: 10.1177/1203475421991130
doi:
Substances chimiques
Antigens, Fungal
0
Measles-Mumps-Rubella Vaccine
0
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM